Phreesia EBIT Margin 2019-2025 | PHR

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Phreesia (PHR) over the last 10 years. The current EBIT profit margin for Phreesia as of January 31, 2025 is .
Phreesia EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2025-01-31 $0.42B $-0.06B -13.81%
2024-10-31 $0.41B $-0.08B -19.75%
2024-07-31 $0.39B $-0.10B -25.13%
2024-04-30 $0.37B $-0.12B -31.55%
2024-01-31 $0.36B $-0.14B -38.38%
2023-10-31 $0.34B $-0.15B -43.36%
2023-07-31 $0.32B $-0.16B -48.44%
2023-04-30 $0.30B $-0.16B -54.30%
2023-01-31 $0.28B $-0.18B -62.99%
2022-10-31 $0.26B $-0.18B -70.23%
2022-07-31 $0.25B $-0.18B -73.47%
2022-04-30 $0.23B $-0.16B -69.30%
2022-01-31 $0.21B $-0.12B -55.40%
2021-10-31 $0.20B $-0.08B -40.10%
2021-07-31 $0.18B $-0.05B -27.37%
2021-04-30 $0.16B $-0.03B -19.02%
2021-01-31 $0.15B $-0.03B -16.89%
2020-10-31 $0.14B $-0.02B -15.83%
2020-07-31 $0.13B $-0.02B -13.43%
2020-04-30 $0.13B $-0.02B -12.31%
2020-01-31 $0.13B $-0.02B -12.00%
2019-07-31 $0.08B $-0.01B -13.10%
2019-04-30 $0.08B $-0.01B -10.26%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.461B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.687B 52.05
Tempus AI (TEM) United States $9.349B 0.00
Hims & Hers Health (HIMS) United States $7.785B 125.14
Inspire Medical Systems (INSP) United States $4.759B 92.44
IRhythm Technologies (IRTC) United States $3.404B 0.00
Privia Health (PRVA) United States $2.840B 212.82
Enovis (ENOV) United States $1.994B 12.34
Schrodinger (SDGR) United States $1.883B 0.00
Clover Health Investments (CLOV) United States $1.763B 0.00
Omnicell (OMCL) United States $1.471B 31.72
Azenta (AZTA) United States $1.216B 56.62
10x Genomics (TXG) United States $1.025B 0.00
Butterfly Network (BFLY) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Talkspace (TALK) United States $0.532B 316.00
Veradigm (MDRX) United States $0.457B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.389B 0.00
Claritev (CTEV) United States $0.373B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Pulmonx (LUNG) United States $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.211B 0.00
Nyxoah SA (NYXH) Belgium $0.204B 0.00
American Well (AMWL) United States $0.114B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.082B 0.00
CareCloud (CCLD) United States $0.077B 3.31
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.041B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00